E8T-25576-00118
5 vaccinations
5 coded responses
62 check-ins
5 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 152 / PA
- Registered
- 2021-02-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-15
Registered in v-safe
-
2021-02-15
Dose 1 — Pfizer-BioNTech
- 2021-02-15
- 2021-02-16
- 2021-02-17
- 2021-02-18
- 2021-02-19
- 2021-02-20
- 2021-02-21
- 2021-02-22
- 2021-03-01
-
2021-03-08
Dose 2 — Pfizer-BioNTech
- 2021-03-08
-
2021-03-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-10
- 2021-03-11
- 2021-03-12
- 2021-03-13
- 2021-03-14
- 2021-03-15
- 2021-03-22
- 2021-03-29
- 2021-04-05
- 2021-04-12
- 2021-04-19
-
2021-06-07
Survey response — 3 months, dose 2MedDRA: Respiratory tract congestion, Rhinorrhoea, Sneezing — Feeling: GoodFree text: Runny nose, congestion, sneezing for about 5 days 5/12-5/17/21. No fever, no cough, no respiratory difficulty. Grandson, with whom I had close prior contact, had similar symptoms. Resolved on its own; no subsequent symptoms.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-09-06
Survey response — 6 months, dose 2MedDRA: Atrial fibrillation — Feeling: GoodFree text: Diagnosed with atrial fibrillation on 8/11/21.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-09-29
Dose 3 — Pfizer-BioNTech
- 2021-10-03
- 2021-10-04
- 2021-10-05
- 2021-10-06
- 2021-10-13
- 2021-10-20
- 2021-10-27
- 2021-11-03
- 2021-11-11
- 2021-12-29
-
2022-03-30
Survey response — 6 months, dose 3MedDRA: Cough, Nasal congestion, Rhinorrhoea, Upper respiratory tract infection — Feeling: FairFree text: Upper respiratory infection with nasal congestion, runny nose, and cough. No fever.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-14
Dose 4 — Pfizer-BioNTech
-
2022-04-15
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Chills, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-04-16
- 2022-04-17
- 2022-04-18
- 2022-04-19
- 2022-04-20
- 2022-04-21
- 2022-04-28
- 2022-05-05
-
2022-05-12
Survey response — day 28, dose 4MedDRA: Cough, Nasal congestion, SARS-CoV-2 test negative, Upper respiratory tract infection — Feeling: FairFree text: Upper respiratory infection with nasal congestion & cough. Home COVID tests negative on 5/8 and 5/9.MedDRA releases: 2024-11 · check-in free text available
- 2022-05-19
- 2022-05-26
- 2022-07-14
-
2022-10-08
Dose 5 — Pfizer-BioNTechCo-administered: Flu
-
2022-10-09
Survey response — days 1–6 daily, dose 5MedDRA: No adverse event — Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: NoMedDRA releases: 2024-11 · check-in free text available
- 2022-10-10
- 2022-10-11
- 2022-10-12
- 2022-10-13
- 2022-10-14
- 2022-10-15
- 2022-10-22
- 2022-10-29
- 2022-11-05
- 2022-11-12
- 2022-11-19
- 2023-01-07
- 2023-04-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-15 | Pfizer-BioNTech | |
| 2 | 2021-03-08 | Pfizer-BioNTech | |
| 3 | 2021-09-29 | Pfizer-BioNTech | No |
| 4 | 2022-04-14 | Pfizer-BioNTech | No |
| 5 | 2022-10-08 | Pfizer-BioNTech | Flu |
Free text
Release 8 — 3 months, dose 2
Symptoms: Runny nose, congestion, sneezing for about 5 days 5/12-5/17/21. No fever, no cough, no respiratory difficulty. Grandson, with whom I had close prior contact, had similar symptoms. Resolved on its own; no subsequent symptoms.
Release 9 — 6 months, dose 2
Symptoms: Diagnosed with atrial fibrillation on 8/11/21.
Release 11 — 6 months, dose 3
Symptoms: Upper respiratory infection with nasal congestion, runny nose, and cough. No fever.
Release 11 — day 28, dose 4
Symptoms: Upper respiratory infection with nasal congestion & cough. Home COVID tests negative on 5/8 and 5/9.
Release 12 — days 1–6 daily, dose 5
Systemic reaction (other): No
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Atrial fibrillation | ✓ | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Sneezing | ✓ | ✓ | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SRO | No adverse event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release